Effects of E4/DRSP on self-reported physical and emotional premenstrual and menstrual symptoms: Pooled data from two phase 3 clinical trials

Céline Bouchard, Johannes Bitzer + Show 3 more

https://doi.org/10.1016/j.jogc.2023.03.027

Copy DOI

Publication Date: May 1, 2023

Abstract

To describe the effects of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg (24/4 regimen) on premenstrual and menstrual symptoms.

Full Text

Published version (

Free)

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author